Compare key investment metrics of 한미약품 and 138610 in real time. Both stocks belong to the 펩타이드 신약 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- On earnings-based valuation, 138610 trades at a lower PER — 26.78x vs 한미약품's 29.87x. A lower PER can suggest undervaluation, but differences in growth expectations should also be considered.
- By market capitalization, 한미약품 is larger — ₩5.2T vs 138610's ₩197B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 한미약품's current price of 401,500원 sits at about 35% of its 52-week range (266,500원–648,000원).
- 138610's current price of 17,300원 sits at about 2% of its 52-week range (16,630원–54,700원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 한미약품 | 138610 |
|---|---|---|
| Price | 401,500원 | 17,300원 |
| PER | 29.87배 | 26.78배 |
| PBR | 3.92배 | 4.18배 |
| Dividend Yield | 0.5% | - |
| Market Cap | ₩5.2T | ₩197B |
| 52-Week High | 648,000원 | 54,700원 |
| 52-Week Low | 266,500원 | 16,630원 |
As of 2026-06-24 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 한미약품 or 138610?
As of 2026-06-24, 138610 has the lower PER — about 26.78x vs 한미약품's 29.87x. PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share; a lower PER may suggest undervaluation, but growth expectations should also be considered.
What is the dividend yield difference between 한미약품 and 138610?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 한미약품 and 138610 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 한미약품 and 138610?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.